Robitussin Cough Long-Acting (dextromethorphan HBr) | ROBITUSSIN COUGH LONG-ACTING
Dextromethorphan HBr, USP 15 mg
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
|children under 12 years||do not use|
|adults and children 12 years and over||2 teaspoons every 6 to 8 hours|
alcohol, anhydrous citric acid, artificial & natural flavors, FD&C red no. 40, glycerin, high fructose corn syrup, liquid glucose, menthol, purified water, saccharin sodium, sodium benzoate
Call weekdays from 9 AM to 5 PM EST at 1-800-762-4675
The product packaging shown below represents a sample of that currently in use. Additional packaging may also be available.
See New Dosing Information
Robitussin Cough LONG-ACTING
DEXTROMETHORPHAN HBr (Cough Suppressant)
Cough: Up to 8 Hours
For Ages 12 & Over
4 FL OZ (118 mL)
Choosing the right product is important. Robitussin has different products for adults and for children.
Ages 12 & Over
Ages Under 12
Use as directed
DOSAGE CUP INCLUDED
Wyeth Consumer Healthcare
Madison, NJ 07940 U.S.A.
For most recent product information, visit www.robitussin.com
PARENTS: Learn about teen medicine abuse www.StopMedicineAbuse.org
Packaged with Tamper-Evident bottle cap. Do Not Use if breakable ring is separated or missing.
Richmond Division of Wyeth
Drugs and Medications
Robitussin Cough & Cold Long-Acting(chlorpheniramine maleate and dextromethorphan HBr)
Children’s Robitussin Cough & Cold Long-Acting(chlorpheniramine maleate and dextromethorphan HBr)
Children’s Robitussin Cough Long-Acting(dextromethorphan HBr)
Robitussin Lingering Cold Long-Acting Cough(dextromethorphan HBr)
Robitussin CoughGels Long-Acting (dextromethorphan HBr)
This is a multi-center extension of Alkermes study ALK21-006 to further assess the long-term safety of repeat monthly doses of naltrexone long acting injection.
This study is being done to find out why some people with mucus dripping down the back of their throat have a nagging cough while others do not cough.
This trial is conducted in Asia, Europe, Japan and North America. The aim of this clinical trial is to investigate the safety and the efficacy of a prophylactic treatment option with long ...
A cough lasting more than 2 months is known as a chronic cough, affecting 12-23% of the adult non-smoking population. Chronic cough has many associated complications including incontinenc...
The purpose of this study is to compare therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in patients with heart failure, and to test our h...
Chronic cough is a common reason for patients to seek medication attention. Over the last few decades, we have experienced significant clinical success by applying the paradigm of 'evaluating and trea...
Cough efficacy assessment is of clinical relevance in neuromuscular patients. Tests of varying complexity and invasiveness, such as cough peak flow (CPF), maximal expiratory pressure (PEmax) and gastr...
The aim was to compare the efficacy of long-acting and short-acting gonadotropin-releasing hormone (GnRH) agonists by long protocol on embryo quality, endometrial thickness and pregnancy rate in in vi...
Beta 2 agonist bronchodilators (β2A) are very important part in the pharmacotherapy of bronchial asthma, a disease that progresses in the world in an epidemic way. The β2A are prescribed to millions...
Combination long-acting bronchodilator therapy may be more effective than long-acting bronchodilator monotherapy in chronic obstructive pulmonary disease (COPD).